Molecular Imaging in Inflammation and Infection

Molecular Inflammation Imaging - Basics & Beacons

• Basics: Visualizes cellular/molecular processes in inflammation/infection non-invasively. Aims for early detection, characterization, and monitoring treatment response.
• Beacons (Probes/Tracers): Target specific biological entities involved in inflammation/infection.
  • Radiolabeled Cells: E.g., $^{99m}$Tc-HMPAO or $^{111}$In-oxine labeled leukocytes.
  • Radiolabeled Antibodies/Fragments: Target specific antigens (e.g., anti-CD15 Ab).
  • Radiolabeled Peptides: E.g., somatostatin receptor analogs, chemotactic peptides.
  • Small Molecules: E.g., $^{18}$F-FDG (glucose analog), radiolabeled antibiotics.
• Ideal Probe Traits: High target affinity & specificity, rapid non-target clearance, favorable dosimetry, easy synthesis.

⭐ $^{18}$F-FDG PET/CT is widely used for detecting inflammation/infection due to increased glucose metabolism in activated inflammatory cells (macrophages, neutrophils).

Key Radiotracers - Infection Illuminators

⭐ Ga-67 localizes via transferrin binding, direct bacterial siderophore uptake, & leukocyte lactoferrin at inflammatory sites.

Clinical Applications - Diagnostic Detectives

• Fever of Unknown Origin (FUO):
  • $^{18}$F-FDG PET/CT: Key modality; detects inflammation, infection, malignancy. High sens.
  • Labelled WBC scan ($^{99m}$Tc-HMPAO / $^{111}$In-oxine): High spec. for infection.
• Osteomyelitis (OM) & Diabetic Foot:
  • $^{18}$F-FDG PET/CT: Differentiates OM vs. Charcot foot. High acc.
  • Labelled WBC scan: Gold std. for OM (non-violated bone).
  • 3-phase bone scan ($^{99m}$Tc-MDP): Sensitive, low spec.
• Prosthetic Joint Infection (PJI):
  • Combined WBC/Marrow scan: High acc. Mismatch (WBC > marrow) indicates infection.
  • $^{18}$F-FDG PET/CT: Useful, esp. chronic PJI. Good Neg Pred Value.

  ⭐ In PJI, combined WBC/Marrow scan ($^{99m}$Tc-SC & $^{111}$In-WBC) is highly specific; incongruent uptake (WBC > marrow) signifies infection.

• Other Key Areas:
  • Vasculitis (Large Vessel): $^{18}$F-FDG PET/CT for activity & extent (e.g., Takayasu).
  • IBD: $^{18}$F-FDG PET/CT for activity assessment, extent.
  • Sarcoidosis: $^{18}$F-FDG PET/CT for active inflammation.

Emerging & Advanced - Future Focus

• Novel Radiotracers:
  • Pathogen-specific agents (e.g., sorbitol-based for bacteria).
  • Immune cell tracking (e.g., $^{89}$Zr-oxine for lymphocytes).
• Theranostics:
  • Combining diagnosis & targeted radionuclide therapy for infections.
• Hybrid Imaging:
  • Enhanced PET/MRI: Superior soft tissue contrast, reduced radiation.
• AI & Machine Learning:
  • Improved lesion detection, quantification, and outcome prediction.
• Reporter Gene Imaging:
  • Monitoring engineered cells or microbial gene expression.

⭐ Key Goal: Developing radiotracers to distinguish active infection from sterile inflammation remains a major research priority.

High‑Yield Points - ⚡ Biggest Takeaways

• FDG-PET/CT is widely used, showing ↑ glucose uptake in inflammatory cells like macrophages and neutrophils.
• ⁶⁷Ga-citrate binds transferrin/lactoferrin, useful for chronic inflammation, sarcoidosis, and PCP.
• Labeled Leukocyte Scans (¹¹¹In, ^99mTc-HMPAO) are highly specific for bacterial infections, e.g., osteomyelitis.
• Differentiating infection from sterile inflammation is a key role, where WBC scans often outperform FDG-PET.
• FDG-PET/CT is also crucial for Fever of Unknown Origin (FUO), vasculitis, and IBD.
• ^99mTc-Monoclonal antibodies (e.g., Sulesomab) target granulocytes for specific infection imaging.